MoleSense Secures €156K in Funding to Develop Molecular Wearables for Maternity Care
MoleSense, an EPFL spin-off, has obtained €156,000 in funding from Venture Kick to pioneer molecular wearable technology specifically for maternity care. These wearables will enable continuous, non-invasive monitoring of key biochemical parameters, aiming to improve healthcare outcomes for mothers and babies.
UnitedHealth Plans to Expand Employment of Physicians to Boost Financial Performance
UnitedHealth is changing its strategy by employing more physicians directly in an effort to improve its financial results and gain better operational control.
Eli Lilly Partners with NVIDIA to Develop Pharmaceutical Industry's Largest AI Supercomputer
Eli Lilly and NVIDIA are collaborating to build the largest AI supercomputer in the pharmaceutical sector, aiming to significantly boost research and development through cutting-edge technology.
UnitedHealth Reports Strong Q3 Performance with Positive Profit Outlook and Growth Plans
UnitedHealth's Q3 earnings highlight effective cost control and a raised profit forecast, reflecting progress in its turnaround strategy under CEO Stephen Hemsley. The company anticipates growth in 2026 with stable revenues and increased prescription benefit management income, reassuring investors amid ongoing healthcare industry challenges.
Obamacare Marketplace Health Insurance Costs to Rise Over 25% in 2026
In 2026, health insurance costs on the Obamacare marketplace will rise by over 25%, with states using Healthcare.gov seeing larger premium increases compared to states managing their own marketplaces.
Human Health Raises €4.7M to Advance Patient-Centered Precision Health
Human Health, a London-based precision health platform prioritizing patients, secured €4.7 million in seed funding from multiple investors to expand its services. This investment will aid in further developing their patient-focused healthcare solutions.
Thermo Fisher to Acquire Clario, a Drug Trial Software Company, for up to $9.4 Billion
Thermo Fisher Scientific is acquiring Clario, a drug trial software firm, for up to $9.4 billion in a major private equity deal. This acquisition enhances Thermo Fisher's position in the life sciences technology market.
New Research Sheds Light on Immune System Changes with Aging
A recent study provides new understanding of the immune system's transformation throughout the aging process. This insight could influence future healthcare approaches for older adults, highlighting the importance of immune health in aging populations.
Novo Nordisk Enters Bidding War to Acquire Obesity Biotech Metsera, Rivaling Pfizer
Novo Nordisk is actively competing with Pfizer to acquire Metsera, a biotech firm focused on obesity treatments. This bidding war highlights intense competition in the healthcare and biotech industries for innovative obesity solutions.
Trump Administration Slashes Federal Mental Health and Addiction Agency Staffing
Under the Trump administration, the federal agency dedicated to mental health and addiction treatment has experienced drastic staffing reductions, with its workforce being cut by more than half. This dismantling impacts the agency's ability to address mental health and addiction issues effectively.
Inside Moderna's Crisis: From Global Hero to Facing Unprecedented Challenges
Moderna, renowned for its pivotal role in global health advancements, now confronts the most challenging crisis in its 15-year history, signaling significant internal and external struggles.
Novartis Approaches Acquisition of Avidity Biosciences
Novartis is close to finalizing a deal to acquire Avidity Biosciences with an offer of over $70 per share, marking a significant move in the pharmaceutical industry.
Fitbit Launches Personal Health Coach Preview for Premium Users
Fitbit introduces a personal health coach preview for eligible U.S. Fitbit Premium users, offering personalized support to enhance health and wellness.
Intellia Therapeutics Halts Late-Stage CRISPR Trials Following Patient Safety Issue
Intellia Therapeutics has temporarily suspended two late-stage CRISPR gene-editing clinical trials due to safety concerns after a patient was hospitalized with liver damage. The pause aims to ensure patient safety while the issue is thoroughly investigated.
Intellia Therapeutics Faces Critical Challenge Over CRISPR Drug Safety Concerns
Intellia Therapeutics is struggling to survive as its CRISPR gene-editing drug is associated with severe liver toxicity, posing a significant safety threat to its future.
Insights into 27 Years of IVF Treatments in the U.K.
This article highlights key trends from 27 years of IVF treatments in the U.K., offering insight into advancements and outcomes over time. It also provides additional health news covered in the Morning Rounds newsletter for a broader healthcare perspective.
OpenAI Collaborates with Mental Health Experts to Enhance ChatGPT's Support Amid High User Engagement
OpenAI is working with mental health experts to improve ChatGPT's responses to users experiencing mental health emergencies. ChatGPT has a large user base with 800 million weekly active users, highlighting the importance of effective support through AI.
How Bambu Ventures Acquired Telemedicine Firm Lemonaid Amid 23andMe Bankruptcy
Bambu Ventures acquired telemedicine company Lemonaid Health from 23andMe’s bankruptcy for $10 million, far below its prior $400 million valuation. The deal reflects a unique merger of venture capital and private equity strategies to revive the company independently while expanding healthcare access. Bambu aims to boost growth through marketing and product development, demonstrating an innovative approach to distressed assets in the telehealth market.
Ipsen Acquires French Biotech Company ImCheck Therapeutics for €1 Billion to Strengthen Oncology Pipeline
Ipsen has acquired ImCheck Therapeutics, a French biotech innovator in immuno-oncology, for €1 billion, enhancing its oncology portfolio and commitment to cancer treatment innovation.
roclub Secures $11.7M in Series A to Expand Medtech Staffing Teleoperation Platform
roclub has raised $11.7 million in Series A funding led by Smedvig Ventures and YZR Capital to expand its teleoperation platform addressing staffing shortages in medical technology. This funding will support the company's growth and scaling of solutions in the medtech sector.